Takeda Announces European Medicines Agency Acceptance of Ixazomib's Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma
August 21, 2015 at 04:27 AM EDT
Takeda Pharmaceutical Company Limited (OTC: TKPYY) today announced that the European Medicines Agency (EMA) has ...
